|
Market Closed -
Australian S.E.
04:12:42 09/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 183.84 AUD | +1.31% |
|
+4.84% | +6.48% |
| 09/10 | CSL to Transition US Plasma Centers to Haemonetics' Latest Plasmapheresis Platform | MT |
| 09/10 | Haemonetics Shares Gain as CSL Targets Rollout of Company's Devices by End of 2027 | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- CSL Stock
- Consensus CSL Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
